CS
ELV icon

Credit Suisse’s Elevance Health ELV Stock Holding History

Credit Suisse’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-4,100
Closed -$1.9M – 3824
2021
Q4 		$1.9M Buy
4,100
+1,500
+58% +$631K ﹤0.01% 2828
2021
Q3 		$969K Buy
+2,600
New +$988K ﹤0.01% 3370
2021
Q2 		– Sell
-3,800
Closed -$1.36M – 4491
2021
Q1 		$1.36M Sell
3,800
-6,300
-62% -$2.03M ﹤0.01% 3092
2020
Q4 		$3.24M Sell
10,100
-2,900
-22% -$890K ﹤0.01% 2441
2020
Q3 		$3.49M Sell
13,000
-47,100
-78% -$12.7M ﹤0.01% 2029
2020
Q2 		$15.8M Buy
60,100
+50,100
+501% +$13.4M 0.01% 1066
2020
Q1 		$2.27M Sell
10,000
-5,000
-33% -$1.36M ﹤0.01% 2053
2019
Q4 		$4.53M Sell
15,000
-6,500
-30% -$1.79M ﹤0.01% 1951
2019
Q3 		$5.16M Buy
21,500
+6,500
+43% +$1.78M ﹤0.01% 1742
2019
Q2 		$4.23M Buy
15,000
+13,600
+971% +$3.72M ﹤0.01% 1868
2019
Q1 		$402K Sell
1,400
-5,000
-78% -$1.45M ﹤0.01% 3458
2018
Q4 		$1.68M Buy
6,400
+1,400
+28% +$385K ﹤0.01% 2367
2018
Q3 		$1.37M Hold
5,000
– – ﹤0.01% 2630
2018
Q2 		$1.19M Buy
+5,000
New +$1.16M ﹤0.01% 2881
2014
Q1 		– Sell
-786,700
Closed -$72.7M – 4707
2013
Q4 		$72.7M Buy
+786,700
New +$69.9M 0.07% 282

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Credit Suisse's ELV Position: Q1 2024 in Review

Credit Suisse reduced its Elevance Health (ELV) stake by 2.7% in Q1 2024, selling an estimated $5.84M and leaving 422,240 shares worth $219M. The position accounts for 0.21% of the portfolio, ranked #86.

Credit Suisse first reported a position in ELV in Q2 2013 and has held it in 43 quarters since. The position peaked at $255M in Q4 2022. 1,666 funds tracked by Wall St. Rank hold ELV as of Q1 2024.

  • Credit Suisse held 422,240 shares of Elevance Health worth $219M as of Q1 2024.
  • Credit Suisse sold 11,742 Elevance Health shares in Q1 2024, an estimated $5.84M.
  • Elevance Health made up 0.21% of Credit Suisse's portfolio in Q1 2024, its #86 holding.
  • Credit Suisse first reported a position in Elevance Health in Q2 2013 and has held it in 43 quarters since.
  • Credit Suisse's Elevance Health position peaked at $255M in Q4 2022.
  • 1,666 funds tracked by Wall St. Rank held Elevance Health as of Q1 2024.

Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.